AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease
- 31 July 1996
- journal article
- Published by Elsevier in Molecular Brain Research
- Vol. 39 (1-2), 79-88
- https://doi.org/10.1016/0169-328x(96)00003-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Specific Pathological Tau Protein Variants Characterize Pickʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1996
- New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteinsNeuroscience Letters, 1995
- τ Phosphorylation in Human, Primate, and Rat Brain: Evidence that a Pool of τ Is Highly Phosphorylated In Vivo and Is Rapidly Dephosphorylated In VitroJournal of Neurochemistry, 1994
- Assembly of Alzheimer‐like filaments from full‐length tau proteinFEBS Letters, 1994
- Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5FEBS Letters, 1993
- Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule bindingNeuron, 1993
- Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's diseaseActa Neuropathologica, 1990
- Characterization of two pathological Tau protein variants in Alzheimer brain corticesJournal of the Neurological Sciences, 1989
- Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filamentsJournal of the Neurological Sciences, 1986
- The distribution of tau in the mammalian central nervous system.The Journal of cell biology, 1985